Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography

NCT00162084 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00162084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2005
Completion date
Not reported
Enrollment
2,000
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease, ischemic heart disease